The effect of modifiers of microsomal enzymes on chemical oncogenesis in cultures of C3H mouse cell lines.
Two cell lines, both derived from the C3H mouse and each having different responses (oncogenic and cytotoxic) to polycyclic aromatic hydrocarbon oncogens, were studied with respect to their drug-metabolizing enzymes. The 10T1/2CL8 cells (a C3H mouse embryo fibroblastic cell line) were much more effective in converting 3-methylcholanthrene (3-MC) to 3-MC water-soluble metabolites, 3-MC phenols, and 3-MC-bound cellular macromolecules than were CVP3SC6 cells (a new line of C3H mouse adult ventral prostate fibroblasts). Basal aryl hydrocarbon hydroxylase activity was higher in 10T1/2CL8 cells than in CVP3SC6 cells, while the reverse was found for epoxide hydrase activity (using 3-methylcholanthrene-11, 12-oxide as substrate. 3-MC or benz(a)anthracene induced epoxide hydrase activity in both cell lines to about the same extent. 3-MC did not induce aryl hydrocarbon hydroxylase activity in CVP3SC6 cells. Aryl hydrocarbon hydroxylase activity was markedly induced in both cell lines by benz(a)anthracene and was slightly induced in 10T1/2CL8 cells by 3-MC. In a chemical oncogenesis cell culture system, transformation of 10T1/2CL8 cells mediated by 3-MC could be increased two- to threefold by treating the cell cultures with: either benz(a)anthracene, styrene oxide, cyclohexene oxide, or 1,2,3,4-tetrahydrona=phthalene-1,2-oxide; or with cyclohexene or 1,2-dihydrona-phthalene, alkene precursors of cyclohexene oxide and 1,2,3,4-tetrahydronaphthalene-1,2-oxide, respectively. When 10T1/2CL8 cells were treated with a combination of  benz(a)anthracene and cyclohexene, 3-MC-mediated transformation was increased 7.8-fold. CVP3SC6 cells that were not transformed by 3-MC or other hydrocarbon oncogens were transformed by a combined treatment with benz(a)anthracene, 1,2-dihydronaphthalene, and 3-MC.
D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D001551:Benz(a)Anthracenes / Q000378:metabolism / Q000494:pharmacology; D002273:Carcinogens / Q000378:metabolism*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D003510:Cyclohexanes / Q000494:pharmacology; D004357:Drug Synergism; D004790:Enzyme Induction; D004851:Epoxide Hydrolases / Q000378:metabolism; D004988:Ethers, Cyclic / Q000494:pharmacology; D008748:Methylcholanthrene / Q000378:metabolism; D008861:Microsomes / Q000201:enzymology*; D009281:Naphthalenes / Q000494:pharmacology; D013343:Styrenes / Q000494:pharmacology
D001551:Benz(a)Anthracenes; D002273:Carcinogens; D003510:Cyclohexanes; D004988:Ethers, Cyclic; D009281:Naphthalenes; D013343:Styrenes; D008748:Methylcholanthrene; D001189:Aryl Hydrocarbon Hydroxylases; D004851:Epoxide Hydrolases